Christopher Grant Doughty serves as Executive at CRESCENT BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Christopher Grant Doughty has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 15, 2025 involved receiving (via award) 8,000 shares valued at $0.
Christopher Grant Doughty currently holds 62,194 shares of CRESCENT BIOPHARMA, INC. (CBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Grant Doughty has been a net neutral trader of CBIO stock. They have purchased $0 and sold $0 worth of shares.
Christopher Grant Doughty's most recent insider trade was on Dec 15, 2025, when they sold 8,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |